# Chronic Hepatitis D Virus Infection: Developing Drugs for Treatment  Guidance for Industry - FDA Guidance Document

Source: https://www.globalkeysolutions.net/guidances/guidance-document/chronic-hepatitis-d-virus-infection-developing-drugs-for-treatment-guidance-for-industry/a162cb79-9621-497d-a34f-dd8e97dfa9b3

> FDA guidance document: Chronic Hepatitis D Virus Infection: Developing Drugs for Treatment  Guidance for Industry. Issue date: November 01, 2019. Get complete insights and analysis.

---

## Details

- Title: Chronic Hepatitis D Virus Infection: Developing Drugs for Treatment  Guidance for Industry
- Communication Type: Guidance Document
- Product Type: drugs
- Office Name: Center for Drug Evaluation and Research
- Office URL: /offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c
- Issue Date: 2019-11-01
- Comment Close Date: 2020-01-01
- Last Changed: 2019-10-31
- Docket Number: <a href="https://www.regulations.gov/docket/FDA-2019-D-4042">FDA-2019-D-4042</a>

## Related Documents

- [Stimulant Use Disorders: Developing Drugs for Treatment](https://www.globalkeysolutions.net/guidances/guidance-document/stimulant-use-disorders-developing-drugs-for-treatment/396da81b-e089-444c-9781-b40a43a1cff2)
- [Nonalcoholic Steatohepatitis with Compensated Cirrhosis: Developing Drugs for Treatment Guidance for Industry](https://www.globalkeysolutions.net/guidances/guidance-document/nonalcoholic-steatohepatitis-with-compensated-cirrhosis-developing-drugs-for-treatment-guidance-for-industry/71c114f5-4930-4cda-87ef-12936678931f)
- [Respiratory Syncytial Virus Infection: Developing Antiviral Drugs for Prophylaxis and Treatment Guidance for Industry](https://www.globalkeysolutions.net/guidances/guidance-document/respiratory-syncytial-virus-infection-developing-antiviral-drugs-for-prophylaxis-and-treatment-guidance-for-industry/59a11b52-4b6d-43c3-a5e2-4d57eedf16bc)